HOOKIPA Pharma HOOK

$ 2.35 -13.6%

Quarterly report 2024-Q3
added 11-14-2024

HOOKIPA Pharma Financial Statements 2011-2024 | HOOK

Annual Financial Statements HOOKIPA Pharma

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	67.1 M	54.4 M	76.5 M	289 M	226 M	-	-	-	-	-	-	-	-
Shares	94.5 M	65.5 M	32.8 M	26 M	17.9 M	-	-	-	-	-	-	-	-
Historical Prices	0.71	0.83	2.33	11.1	12.2	-	-	-	-	-	-	-	-
Net Income	-81.6 M	-64.9 M	-75.7 M	-44.1 M	-43 M	-16.2 M	-12.7 M	-	-	-	-	-	-
Revenue	20.1 M	14.2 M	18.4 M	19.6 M	11.9 M	7.63 M	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-97.7 M	-73.2 M	-81.7 M	-53.3 M	-51.1 M	-21.2 M	-14.2 M	-	-	-	-	-	-
Interest Expense	317 K	687 K	898 K	786 K	877 K	778 K	606 K	-	-	-	-	-	-
EBITDA	-94.1 M	-69.6 M	-77 M	-49.1 M	-42.9 M	-14.9 M	-11.7 M	-	-	-	-	-	-
Operating Expenses	-	-	-	-	56.3 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	18.6 M	18.8 M	17.3 M	18.1 M	16.7 M	6.84 M	4.38 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement HOOKIPA Pharma

	2024-Q3	2024-Q2	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	12.5 M	12.5 M	11 M	8.27 M	72.2 M	-	72.2 M	72.2 M	45 M	-	32.9 M	32.8 M	32.8 M	-	25.7 M	25.6 M	25.6 M	-	25.4 M	19.2 M	1.01 M	1.01 M	912 K	912 K	912 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-13.8 M	-19.1 M	-19.1 M	-18 M	-19.7 M	-	-18.3 M	-16.4 M	-18 M	-	-20 M	-17.2 M	-17.2 M	-12.5 M	-44.1 M	-44.1 M	-44.1 M	-10.2 M	-43 M	-43 M	-43 M	-1.89 M	-3.95 M	-5.82 M	-4.57 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	4.7 M	1.29 M	6.87 M	2.68 M	3.18 M	-	2.23 M	2.75 M	1.44 M	-	3.87 M	5.38 M	5.3 M	5.16 M	4.04 M	6.68 M	3.7 M	3.62 M	2.04 M	4.05 M	2.24 M	5.08 M	1.9 M	649 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-18.6 M	-22.5 M	-22.7 M	-21.5 M	-22.7 M	-	-21 M	-18.4 M	-20.1 M	-	-21.2 M	-19.3 M	-19.2 M	-	-16.4 M	-9.23 M	-12.5 M	-	-13.6 M	-13.6 M	-10.7 M	-	-5.55 M	-6.98 M	-6.45 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	1.81 M	-218 K	-833 K	25 K	122 K	-	105 K	231 K	243 K	-	234 K	218 K	219 K	-	194 K	166 K	227 K	-	227 K	210 K	213 K	-	194 K	191 K	193 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-21.7 M	-	-18.3 M	-16.5 M	-19.1 M	-	-17.8 M	-17 M	-18.1 M	-	-13.4 M	-7.35 M	-11.6 M	-	-12.5 M	-13 M	-10.4 M	-	-5.09 M	-6.68 M	-6.31 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	20.4 M	20.4 M	15.9 M	16.2 M	16.8 M	15.6 M	17.7 M	12.9 M	7.28 M	7.45 M	7.62 M	6.45 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	6.73 M	3.94 M	4.91 M	4.44 M	4.9 M	-	4.94 M	5.03 M	4.97 M	-	4.34 M	5.1 M	4.31 M	-	4.44 M	4.35 M	4.63 M	-	4.59 M	3.75 M	2.71 M	-	1.28 M	1.41 M	1.48 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency